Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
Blue curve MMWR spacer

Notice to Readers Licensure of Varicella Virus Vaccine, Live

On March 17, 1995, the Food and Drug Administration licensed Varicella Virus Vaccine, Live (VARIVAX {registered symbol}), manufactured and distributed by Merck and Co., Inc., (Rahway, New Jersey). This vaccine has been licensed for use in persons aged greater than or equal to 12 months. The recommended dose for susceptible children aged 12 months-12 years is one 0.5 mL dose administered subcutaneously. The recommended dosage for susceptible adolescents aged greater than or equal to 13 years and adults is two 0.5 mL doses of vaccine 4-8 weeks apart.

The recommendations of the Advisory Committee on Immunization Practices on the use of varicella vaccine will be published. Reported by: Center for Biologics Evaluation and Research, Food and Drug Administration. National Immunization Program, CDC.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to

Page converted: 09/19/98


Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A


Department of Health
and Human Services

This page last reviewed 5/2/01